Sentinel Node Biopsy Market Forecast and Oncology Outlook
The Sentinel Node Biopsy Market forecast suggests sustained growth as healthcare systems prioritize minimally invasive cancer staging. Forecast models indicate an increasing preference for SNB in breast cancer treatment, where the procedure limits surgical morbidity while providing accurate tumor spread data.
Breast cancer remains the dominant application, but rising melanoma cases also contribute significantly. Forecasts highlight ongoing adoption of hybrid tracers and fluorescent imaging, both of which enhance surgical accuracy. Furthermore, AI-based predictive analytics are expected to play a central role in optimizing patient selection for SNB in the coming decade.
By combining clinical evidence with healthcare spending patterns, the forecast predicts steady expansion across developed and emerging markets.
FAQs
Q1: What drives the SNB market forecast?Cancer prevalence, hybrid tracers, and AI-based diagnostics.
Q2: Which cancer type dominates forecasts?Breast cancer, followed by melanoma.